{"id":"https://openalex.org/W2292125503","doi":"https://doi.org/10.1093/jpids/piv084","title":"Nevirapine Plasma Concentrations in Human Immunodeficiency Virus-Exposed Neonates Receiving High-Dose Nevirapine Prophylaxis as Part of 3-Drug Regimen","display_name":"Nevirapine Plasma Concentrations in Human Immunodeficiency Virus-Exposed Neonates Receiving High-Dose Nevirapine Prophylaxis as Part of 3-Drug Regimen","publication_year":2016,"publication_date":"2016-01-23","ids":{"openalex":"https://openalex.org/W2292125503","doi":"https://doi.org/10.1093/jpids/piv084","mag":"2292125503","pmid":"https://pubmed.ncbi.nlm.nih.gov/26803329"},"language":"en","primary_location":{"id":"doi:10.1093/jpids/piv084","doi":"https://doi.org/10.1093/jpids/piv084","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jpids/piv084","pdf_url":null,"source":{"id":"https://openalex.org/S2912147776","display_name":"Journal of the Pediatric Infectious Diseases Society","issn_l":"2048-7193","issn":["2048-7193","2048-7207"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Pediatric Infectious Diseases Society","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040230617","display_name":"Michael Bolaris","orcid":"https://orcid.org/0000-0002-7787-9928","observed_orcids":["https://orcid.org/0000-0002-7787-9928"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210165985","display_name":"Harbor\u2013UCLA Medical Center","ror":"https://ror.org/05h4zj272","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I4210165985"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Bolaris","raw_affiliation_strings":["Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles County Harbor UCLA Medical Center, Torrance, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles County Harbor UCLA Medical Center, Torrance, California","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4210165985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103548495","display_name":"Margaret Keller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210165985","display_name":"Harbor\u2013UCLA Medical Center","ror":"https://ror.org/05h4zj272","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I4210165985"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret A. Keller","raw_affiliation_strings":["Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles County Harbor UCLA Medical Center, Torrance, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles County Harbor UCLA Medical Center, Torrance, California","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4210165985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074025567","display_name":"Brian L. Robbins","orcid":"https://orcid.org/0000-0001-6809-9252","observed_orcids":["https://orcid.org/0000-0001-6809-9252"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian L. Robbins","raw_affiliation_strings":["Antiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000852039","display_name":"Anthony T. Podany","orcid":"https://orcid.org/0000-0002-8371-0379","observed_orcids":["https://orcid.org/0000-0002-8371-0379"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony T. Podany","raw_affiliation_strings":["Antiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017051528","display_name":"Courtney Vail Fletcher","orcid":"https://orcid.org/0000-0002-3703-7849","observed_orcids":["https://orcid.org/0000-0002-3703-7849"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtney V. Fletcher","raw_affiliation_strings":["Antiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha","institution_ids":["https://openalex.org/I59130452"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4752,"currency":"USD","value_usd":4752},"apc_paid":null,"fwci":1.2301,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.79692966,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"6","issue":"1","first_page":"piv084","last_page":"piv084"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.8794000148773193,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.8794000148773193,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.10970000177621841,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7200000286102295},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.6930000185966492},{"id":"https://openalex.org/keywords/perinatal-hiv-transmission","display_name":"perinatal HIV transmission","score":0.7329999804496765},{"id":"https://openalex.org/keywords/functional-cure","display_name":"functional cure","score":0.6159999966621399},{"id":"https://openalex.org/keywords/neonatal-drug-safety","display_name":"drug safety in neonates","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.9713037014007568},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9241503477096558},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.7339720726013184},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5487995743751526},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4975185692310333},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4493083953857422},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42428410053253174},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3398417532444},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28353121876716614},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.14405322074890137},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.13054776191711426}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005189","descriptor_name":"False Positive Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007231","descriptor_name":"Infant, Newborn","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011247","descriptor_name":"Pregnancy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011251","descriptor_name":"Pregnancy Complications, Infectious","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D016133","descriptor_name":"Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018445","descriptor_name":"Infectious Disease Transmission, Vertical","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1093/jpids/piv084","doi":"https://doi.org/10.1093/jpids/piv084","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jpids/piv084","pdf_url":null,"source":{"id":"https://openalex.org/S2912147776","display_name":"Journal of the Pediatric Infectious Diseases Society","issn_l":"2048-7193","issn":["2048-7193","2048-7207"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Pediatric Infectious Diseases Society","raw_type":"journal-article"},{"id":"pmid:26803329","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26803329","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Pediatric Infectious Diseases Society","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7900000214576721}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1984745693","https://openalex.org/W2094360047","https://openalex.org/W2120110886","https://openalex.org/W2122846238","https://openalex.org/W2130560337","https://openalex.org/W2165315339"],"related_works":["https://openalex.org/W3109629542","https://openalex.org/W2894526307","https://openalex.org/W4297851374","https://openalex.org/W3135606052","https://openalex.org/W2005206478","https://openalex.org/W2155050390","https://openalex.org/W2329154031","https://openalex.org/W1977000190","https://openalex.org/W2474911917","https://openalex.org/W2136875051"],"abstract_inverted_index":{"We":[0],"recently":[1],"provided":[2],"care":[3],"for":[4,14,80,106,140,151],"3":[5,168],"human":[6],"immunodeficiency":[7],"virus":[8],"(HIV)-exposed":[9],"babies":[10],"at":[11],"high":[12],"risk":[13],"perinatal":[15],"acquisition":[16],"of":[17,23,27,37,44,50,56,74,103,131,137,143],"HIV.":[18,110],"Since":[19],"the":[20,38,41,47,100,112,116,127,148],"first":[21],"report":[22],"possible":[24,42],"functional":[25],"cure":[26],"1":[28],"baby":[29],"in":[30,134,145,167],"Mississippi":[31],"[1]":[32],"with":[33],"early":[34],"triple-drug":[35],"therapy":[36],"newborn":[39],"and":[40,68,129],"clearance":[43],"HIV":[45],"from":[46],"peripheral":[48],"blood":[49],"another":[51],"infant":[52],"[2],":[53],"optimal":[54],"management":[55],"high-risk,":[57],"HIV-exposed":[58],"infants":[59],"is":[60,94],"being":[61],"reconsidered.":[62],"Early":[63],"initiation":[64],"can":[65],"suppress":[66],"viremia":[67],"leads":[69],"to":[70,98,109,125],"a":[71,78,96,123],"smaller":[72],"number":[73],"infected":[75],"cells":[76],"as":[77],"reservoir":[79],"continued":[81],"infection":[82],"[3].":[83],"The":[84],"International":[85],"Maternal":[86],"Pediatric":[87],"Adolescent":[88],"AIDS":[89],"Clinical":[90],"Trials":[91],"(IMPAACT)":[92],"network":[93],"conducting":[95],"study":[97],"examine":[99],"potential":[101,149],"utility":[102],"this":[104,152,155],"approach":[105],"newborns":[107],"exposed":[108],"Despite":[111],"recent":[113],"information":[114],"that":[115],"\u201cMississippi":[117],"baby\u201d":[118],"has":[119],"relapsed,":[120],"there":[121],"remains":[122],"need":[124],"evaluate":[126],"safety":[128],"effectiveness":[130],"high-dose":[132],"nevirapine":[133,144,163],"neonates.":[135],"Lack":[136],"such":[138],"data":[139,161],"treatment":[141],"doses":[142],"neonates":[146],"complicates":[147],"enthusiasm":[150],"approach.":[153],"In":[154],"study,":[156],"we":[157],"present":[158],"unique":[159],"pharmacokinetic":[160],"on":[162],"plasma":[164],"concentrations":[165],"obtained":[166],"newborns.":[169]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}